Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fentanyl for exercise-induced dyspnea in cancer
NCT01856114Phase 2Completed
- Sponsor
- University of Texas MD Anderson Cancer Center
- Start
- May 2014
- Primary completion
- Dec 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of fentanyl (transdermal patch + oral transmucosal lozenge) in Dyspnea, sponsored by University of Texas MD Anderson Cancer Center. Primary endpoint: Dyspnea Numeric Rating Scale at 30 minutes. Started May 2014; status: completed.
02
Drugs
fentanyl (transdermal patch + oral transmucosal lozenge)
03
Conditions
Dyspnea
Beyond the preview
Go deeper on NCT01856114.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01856114.